Are ENT1/ENT1, NOTCH3, and miR-21 Reliable Prognostic Biomarkers in Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Gemcitabine Monotherapy?

Evidence on equilibrative nucleoside transporter 1 (ENT1) and microRNA-21 (miR‑21) is not yet sufficiently convincing to consider them as prognostic biomarkers for patients with pancreatic ductal adenocarcinoma (PDAC). Here, we investigated the prognostic value of ENT1/ENT1, miR-21, and neurogenic l...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiraskova, Lucie, Ryska, Ales, Duintjer Tebbens, Erik Jurjen, Hornychova, Helena, Cecka, Filip, Staud, Frantisek, Cerveny, Lukas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893654/
https://www.ncbi.nlm.nih.gov/pubmed/31652721
http://dx.doi.org/10.3390/cancers11111621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893654/
https://www.ncbi.nlm.nih.gov/pubmed/31652721
http://dx.doi.org/10.3390/cancers11111621

Ejemplares similares